PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
July 26, 2024Frontiers in ImmunologyOpen Access

TACE plus lenvatinib and tislelizumab for intermediate-stage hepatocellular carcinoma beyond up-to-11 criteria: a multicenter cohort study

View Full Paper
Ask AI
Bookmark
Share

Authors

SCSong ChenSTShuang‐Yan TangFSFeng Shi

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Chen et al. (2024) studied this question.

synapsesocial.com/papers/68e5ee7cb6db643587582a71https://doi.org/10.3389/fimmu.2024.1430571
View Full Paper
Ask AI
Bookmark
Share